Skip to main content

Table 1 Demographic details of the COPD and control group

From: Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD

Subjects

Controls

COPD

No. of subjects

14

10

Age (years)

44 (±8)

58 (±16)*

FEV1, % pred

110.4 (±9)

60.5 (±20)

FEV1, % FVC

96 (±12)

58 (±15)*

Male/Female

8/6

6/4

  1. Data showing mean ± SD.
  2. Abbreviations: FEV1 forced expiratory volume in 1 second, FVC forced vital capacity, *P < 0.05 compared to controls.
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us